In particular it will be important to determine whether oxidized ABri can induce disease-relevant changes in tau, and whether the preliminary reports of loss of FBD-BRI2 maturation in end-stage FBD brain are also detected in FBD iPSC-derived neurons. The gene discussed is ITM2B; the disease is ABri amyloidosis.